Trial Profile
The effect of Single tablet of fixed dose Mitiglinide and Voglibose or Linagliptine with Insulin Degludec.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Mitiglinide/voglibose (Primary) ; Insulin degludec
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 11 Apr 2016 Status changed from active, no longer recruiting to completed.
- 11 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 28 Jun 2014 New trial record